Ascorbate maintains a low plasma oxygen level by Injarabian, Louise et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Ascorbate maintains a low plasma oxygen level









Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Injarabian, L., Scherlinger, M., Devin, A., Ransac, S., Lykkesfeldt, J., & Marteyn, B. S. (2020). Ascorbate
maintains a low plasma oxygen level. Scientific Reports, 10(1), [10659]. https://doi.org/10.1038/s41598-020-
67778-w
Download date: 09. okt.. 2020
1Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:10659  | https://doi.org/10.1038/s41598-020-67778-w
www.nature.com/scientificreports
Ascorbate maintains a low plasma 
oxygen level
Louise injarabian1,2, Marc Scherlinger3, Anne Devin2, Stéphane Ransac2, Jens Lykkesfeldt4 & 
Benoit S. Marteyn1,5,6,7*
In human blood, oxygen is mainly transported by red blood cells. Accordingly, the dissolved oxygen 
level in plasma is expected to be limited, although it has not been quantified yet. Here, by developing 
dedicated methods and tools, we determined that human plasma  pO2 = 8.4 mmHg (1.1%  O2). oxygen 
solubility in plasma was believed to be similar to water. Here we reveal that plasma has an additional 
ascorbate-dependent oxygen-reduction activity. Plasma experimental oxygenation oxidizes 
ascorbate (49.5 μM in fresh plasma vs < 2 μM in oxidized plasma) and abolishes this capacity, which is 
restored by ascorbate supplementation. We confirmed these results in vivo, showing that the plasma 
 po2 is significantly higher in ascorbate-deficient guinea pigs  (Ascorbateplasma < 2 μM), compared 
to control  (Ascorbateplasma > 15 μM). Plasma low oxygen level preserves the integrity of oxidation-
sensitive components such as ubiquinol. Circulating leucocytes are well adapted to these conditions, 
since the abundance of their mitochondrial network is limited. These results shed a new light on the 
importance of oxygen exposure on leucocyte biological study, in regards with the reducing conditions 
they encounter in vivo; but also, on the manipulation of blood products to improve their integrity and 
potentially improve transfusions’ efficacy.
Blood gases are either dissolved in the plasma or transported by hematies. The solubility of  O2 is low compared 
to  CO21. Only a limited fraction of  O2 is dissolved in plasma, representing less than 2% of the total blood oxygen 
content. Arterial  pO2 equals 75–100 mmHg (9.9–13.1%  O2) and venous  pO2 equals 30–50 mmHg (3.9–5.6%  O2); 
in theory the blood plasma  pO2 would be ranged from 0.9 to 3 mmHg (0.1–0.4%  O2), although it has not been 
experimentally quantified. Until now, it was considered that the solubility coefficient of  O2 in plasma was similar 
in  water2. The impact of ascorbate (or Vitamin C), a strong reducing molecule, on plasma oxygen level has not 
yet been investigated, despite of its abundance (50–70 μM3,4) and their respective standard redox potentials (E′0 
O2/H2O = 0.815 and E′0DHA/Ascorbate = 0.08)5.
In this report, we confirmed experimentally that plasma is poorly oxygenated and revealed that ascorbate 
contributes to its low oxygenation level, by reducing  O2. The impact of plasma “physiological hypoxia” on circu-
lating cells’ physiology and plasma components’ stability has been further investigated.
Results
Blood plasma is poorly oxygenated. In order to quantify the blood plasma oxygen level, we aimed at 
avoiding non-physiological oxygenation of samples. All commercially available blood collection tubes contain 
a significant amount of oxygen, since they are sealed under atmospheric conditions (Fig. 1A, 75.7 ± 4.6 mmHg; 
9.9 ± 0.6%  O2). To avoid blood experimental oxygenation, we designed and produced tubes containing a lim-
ited amount of oxygen (Fig.  1A, 15.9 ± 2.9  mmHg; 2.1 ± 0.4%  O2) hereafter termed Hypoxytube. These non-
commercial prototype tubes were produced by the Greiner BioOne company. As opposed to commercial tubes, 
hypoxic tubes were sealed under a nitrogen atmosphere, hence limiting their oxygen-content. Immediately after 
blood collection, oxygen level in plasma was quantified with a needle sensor in commercial tubes or Hypoxy-
tubes (Fig. 1B). Plasma  pO2 was 9.8 ± 4.8 mmHg (1.3 ± 0.6%  O2) in commercial tubes versus 8.4 ± 1.0 mmHg 
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Figure 1.  The plasma oxygen level is low, mainly sustained by the ascorbate oxygen. (A) Blood collection 
tubes containing a limited amount of oxygen (Hypoxytubes; picture) have been designed and validated using 
an oximeter with a microsensor equipped with a steel needle. Commercial tube used as a control was BD 
Vacutainer K2E (EDTA). Results are expressed as Mean ± S.D.; **** indicates p < 0.0001, n = 20 (tubes). (B–C) 
Plasma oxygen level was directly quantified in whole venous blood collected in commercial tube or Hypoxytube. 
Plasma  pO2 quantifications are expressed as Mean ± S.D.; ** indicates p < 0.01, n = 12 individual donors. (D) 
Plasma samples were loaded in closed cuve to record the time-dependent oxygen availability in fresh plasma, 
oxidized plasma and water, supplemented or not with 200 μM ascorbate (representative experiment). (E) 
Plasma oxygen reduction rates were quantified in fresh or oxidized plasma samples, as described in (D). 
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(1.1 ± 0.1%  O2) in Hypoxytube (p < 0.01): the latest value being the most accurate quantification of the plasma 
oxygen level (Fig. 1C).
Ascorbate sustains a plasma oxygen-reduction activity. When fresh plasma  pO2 was recorded in a 
closed chamber (Oroboros), a continuous decrease was observed until anoxia was reached (Fig. 1D). This reac-
tion was significantly lower in oxidized plasma or in water (Fig. 1D,E and S1A). These results strongly suggested 
that an oxidation-sensitive plasma component was supporting its oxygen-reduction capacity. We hypothesized 
that plasma ascorbate may play a central role in this reaction. Indeed, the supplementation of oxidized plasma 
with 200 μM ascorbate restored its oxygen reduction activity, not with dehydroascrobate (DHA) (Fig. 1D,F), sup-
porting this hypothesis. However, this reaction does not occur in water (Figure S1A), indicating that the ascor-
bate-dependent oxygen reduction involved other plasma redox components. Additionally, we demonstrated that 
plasma ascorbate concentration (49.5 ± 14.2 μM, Fig. 1G) was drastically reduced in oxidized plasma (p < 0.001, 
Fig. 1H). The concentration of ubiquinol, another oxidation-sensitive plasma component was significantly lower 
in oxidized plasma (p < 0.05, Fig. 1I); in association with an increase of its oxidized form (ubiquinone) (Fig. 1I). 
The concentration of other tested plasma components was unchanged upon plasma oxygenation (salts, proteins 
or additional oxidation-sensitive components (α-tocopherol, γ-tocopherol, Figure S1B–D).
We confirmed the ascorbate-dependent plasma oxygen reduction capacity in vivo, in guinea pigs, which, like 
humans, do not synthesize ascorbate. When animals were fed a standard diet, the plasma ascorbate concentra-
tion was higher than 15 μM and the plasma  pO2 controlled at a low level (24.11 ± 2.23 mmHg; 3.17 ± 0.29%  O2; 
Fig. 1J–K). These values are higher compared to human plasma, probably due to technical reasons (time between 
blood collection and  pO2 measurement). When animals were fed an ascorbate-deficient diet, the plasma ascorbate 
concentration was lower than 2 μM and the plasma  pO2 no longer maintained at a low level (50.40 ± 26.32 mmHg; 
6.63 ± 3.46%  O2) (Fig. 1J–K). Altogether these results confirm the in vivo contribution of ascorbate to the main-
tenance of a low plasma oxygen level.
Circulating leucocytes sense plasma low-oxygenation—mitochondrial network. The adapta-
tion of circulating leucocytes to plasma low oxygen level has not been investigated previously. In other cell-
types, it has been reported that under hypoxic conditions, mitochondrial abundance and oxygen consumption 
is  reduced6–8. We confirmed by immunofluorescence (Fig. 2A) and flow cytometry (Fig. 2B–D) that, compared 
to two different cell lines (HEK293T and HEp-G2) cultured under atmospheric conditions (21%  O2), the mito-
chondrial abundance of leucocytes (granulocytes, monocytes and lymphocytes) was significantly reduced 
(ANOVA, Fig. 2C–D). These results strongly suggest that leucocytes evolve under low oxygen conditions in the 
blood plasma fraction.
Further experiments conducted in vitro at 1%  O2, better reflecting the plasma physiological conditions 
revealed in this study, will have to be performed to support our conclusions.
Discussion
We confirm here experimentally that human plasma has a low oxygen level (< 8.4 mmHg, 1.1%  O2, Fig. 1C) and 
that ascorbate plays a key role in its maintenance (Fig. 1D). Ascorbate is well described and a strong antioxi-
dant in human plasma, which may either scavenge reactive oxygen species (ROS) or regenerate other plasma 
 antioxidants9. Here, we described a physiological and ultimate consequence of the ascorbate reactivity: the 
dissolved plasma oxygen reduction. Plasma ascorbate is highly susceptible to plasma oxygenation and subse-
quent oxidation (Fig. 1E). However, our data indicates that ascorbate does not directly react with oxygen (Fig-
ure S1A), suggesting that other plasma antioxidants may be involved in its oxygen-depletion capacity. It may be 
hypothesized that plasma ascorbate acts as a cofactor and increase the oxygen-reduction ability of other plasma 
components. As an example, ascorbate can bind to human serum albumin, another major antioxidant in the 
 circulation10. Further investigations will be required to decipher the overall partners and reactions.
Interestingly, plasma ascorbate concentration is relatively low in plasma (micromolar range, here 50 ± 14 μM, 
Fig. 1F) compared to human body cells and tissues (millimolar concentrations). Nevertheless, plasma ascorbate 
concentration is tightly controlled, severe ascorbate deficiency (< 5 μM) is associated with scurvy. We observed 
in guinea pigs that in these conditions, the plasma low oxygen level was no longer maintained (Fig. 1K). The 
overall physiological consequences of this regulation defect will have to be further investigated (e.g. red blood 
cell hemoglobin saturation rate, tissue oxygenation efficiency, integrity of other plasma components, leucocyte 
Results are expressed as Mean ± S.D.; * indicates p < 0.05, n = 5 individual samples. (F) The impact of oxidized 
plasma supplementation with ascorbate or dehydroascrobate (DHA) (200 μM) was quantified as described in 
(E). Results are expressed as Mean ± S.D.; ** indicates p < 0.01, n = 4. (G–H) Plasma ascorbate concentration 
in fresh samples was quantified as described in Methods, in blood samples collected in Hypoxytubes (G, 
n = 18 individual samples). The impact of plasma oxygenation on ascorbate concentration is shown in (H, 
n = 4). Results are expressed as Mean ± S.D.; *** indicates p < 0.001. (I) Ubiquinol concentration in fresh and 
oxidized plasma samples was quantified, together with other plasma components (see Figure S1). Results are 
expressed as Mean ± S.D.; * indicates p < 0.05, n = 3 individual samples. (J–K) The impact of plasma ascorbate 
deficiency on the control of the oxygen level has been investigated in vivo in guinea pigs (J–K). Plasma ascorbate 
concentration and  pO2 was recorded in animals fed standard (400 mg ascorbate/kg) or ascorbate-deficient 
diet (< 50 mg ascorbate/kg) (J). Plasma  pO2 was average in each group (plasma ascorbate < 2 μM (deficient) 
and > 15 μM (control)). Results are expressed as Mean ± S.D.; ** indicates p < 0.01, n = 6 animals.
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physiology, among others). In particular, in vitro experiments performed in this study (Fig. 2) were conducted 
at 0%  O2 due to technical limitations.
Further experiments will have to be performed at 1.1%  O2 to even better appreciate the behavior of plasma 
proteins (stability, oxidation) and leucocyte physiology in the blood circulation.
Plasma ascorbate concentration varies with daily oral intakes but remains controlled at relatively low levels. 
If 500 mg ascorbic acid/day is sufficient to maintain a physiological plasma level (50 μM), it was shown that 3 g 
ascorbic acid oral intake every 4 h leads to a maximal plasma ascorbate concentration of only 220 μM11. Mil-
limolar plasma ascorbate concentrations may only be reached upon intravenous administration, as currently 
investigated in the treatment of various cancers, based on the selective cytotoxicity to tumor cells in vitro12. 
Currently, the impact of such high ascorbate concentrations on the plasma  pO2 is unknown and will have to 
be determined. In addition, increased plasma ascorbate concentrations have been shown to be associated with 
an increased production of ascorbate free radicals, a byproduct of self-oxygenation13. These free radicals have 
been proposed to react with transient metal (such as copper and iron), leading to deleterious hydroxyl radical 
production via the Fenton reaction.
Overall, blood plasma low oxygenation level should be better considered for basic research, diagnostics 
and therapeutic applications. As an illustration, this statement is critical during blood products collection and 
preservation prior transfusion to avoid detrimental impact on their  quality14,15.
Figure 2.  The mitochondria abundance is reduced in circulating leucocytes in low-oxygenated plasma. (A) 
Immunofluorescence staining of white blood cells (WBCs: monocytes, lymphocytes and granulocytes) Hep-
G2 cells, and HEK293T cells using anti-CII (mitochondria, red) and DAPI (nuclei, blue). Bars are 10 μm. 
(B) Flow cytometry analysis of WBCs (granulocytes, monocytes and lymphocytes), Hep-G2 and HEK293T. 
Representation of SSC and FSC profiles. (C) TMRM (mitochondria) intensity profiles in granulocytes, 
monocytes, lymphocytes, Hep-G2 and HEK293T cells (representative experiment) (D) Quantification of 
TMRM mean fluorescence intensity (MFI) in cells described in (C). Results are expressed as Mean ± S.D.; **** 
indicates p < 0.0001 (one-way ANOVA with Tukey’s test, see Tables in Figure S2A), n = 4 independent biological 
samples.
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Methods
Blood collection tubes. Blood samples were collected either in commercial collection tubes (BD Vacu-
tainer K2E (EDTA), ref 368,861) or in Hypoxytubes developed in collaboration with the Greiner Bio One (GBO) 
company, containing a limited amount of  O2. (tubes were sealed under a nitrogen atmosphere). Internal  pO2 was 
quantified in commercial tubes and in Hypoxytubes using an oximeter with a microsensor equipped with a steel 
needle (Unisense).
Blood collection. All participants gave written informed consent and all the study procedures were carried 
out in accordance with the Declaration of Helsinki principles. Human blood was collected from healthy patients 
at the ICAReB service of the Pasteur Institut (authorization No. 2020_0120). All donors required to rest in a sit-
ting position for a few minutes before the sampling.
cell culture. HEK293T (ATCC CRL-1573) and Hep-G2 (ATCC HB-8065) were cultured in DMEM + 8% 
SVF. Cells were seeded onto 24-well plates and incubated 24 h at 37 °C at 0% (anoxic cabinet) or 21%  O2.
White blood cells (WBCs) were purified form whole blood in an anoxic chamber by the addition of a 6% 
dextran solution (30 min, RT). The WBC-containing supernatant was collected and resuspended in RPMI 1,640 
(Thermofisher); remaining red blood cells were eliminated with a lysis buffer.
Cells were fixed in paraformaldehyde (PFA) 3.3% for immunofluorescent labelling or labeled with fluorescent 
marker for flow cytometry analysis, as previously  described16.
plasma  po2 measurement and components’ dosage. Immediately after blood collection, the plasma 
 pO2 was measured directly in the blood collection tube using an oximeter with a standardized microsensor 
equipped with a steel needle (Unisense), as previously  described17.
Following centrifugation for 5 min at 2,000×g, the plasma was acidified with an equal volume of 10% (w/v) 
metaphosphoric acid (MPA) containing 2 mmol/L of disodium-EDTA. Ascorbate concentration was quantified 
by high-performance liquid chromatography with coulometric detection, as described  previously18. Likewise, 
using high-performance liquid chromatography with coulometric detection, α- and γ-tocopherol were analyzed 
as described by Sattler et al.19, and ubiquinone and ubiquinol as described  elsewhere20.
Plasma potassium, calcium, magnesium, albumin, fibrinogen, Factor V and Factor VIII were quantified by 
a medical laboratory (Cerballiance, Paris, France).
Plasma oxygen reduction rate quantification. Plasma oxygen consumption rate was measured with 
an oximeter (Oroboros O2k-FluoRespirometer). Immediately after blood collection, samples were centrifuged, 
and plasma fractions were loaded in closed cuves (2 mL). Oxygen consumption fluxes were assessed when reach-
ing constant values. Experiments were conducted with fresh plasma and after oxidation (exposure to atmos-
pheric air: at least 30 min on a rotator mixer).
Mitochondria study. Imaging. Mitochondria were immunolabeled with anti-SDHA antibody (ab14715, 
Abcam) and a conjugated Alexa Fluor-568 (2,124,366, Invitrogen); nuclei with DAPI. Cell imaging was per-
formed with a confocal microscope (Leica DM5500 TCS SPE).
Flow cytometry. Cells were resuspended in PBS + 2 mM EDTA, labeled with 100 nM TMRM (T5428, Sigma-
Aldrich) and analyzed with FACSCcalibur (BD Biosciences). Data were quantified with the FlowJo software 
(FlowJo, LLC).
Guinea pig plasma analysis. 3-week Dunkin–Hartley guinea pigs (Charles River) were fed for fifteen days 
with a standard diet (400 mg ascorbate/kg, Safediet ref. 106) or an ascorbate-deficient diet (< 50 mg ascorbate/
kg). Blood samples were collected in Hypoxytubes; plasma ascorbate concentration and  pO2 were determined as 
described above. Procedure approved by the Institut Pasteur ethics committee (auth. n°190127).
Statistics. Data were analyzed with the Prism 8 software (GraphPad). ANOVA or Student T-test were per-
formed to analyze the different datasets.
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